v3.24.1.1.u2
Cover - USD ($)
$ in Billions
12 Months Ended
Mar. 31, 2024
May 16, 2024
Sep. 30, 2023
Cover [Abstract]      
Document Type 10-K    
Document Annual Report true    
Document Period End Date Mar. 31, 2024    
Current Fiscal Year End Date --03-31    
Document Transition Report false    
Entity File Number 001-37873    
Entity Registrant Name e.l.f. Beauty, Inc.    
Entity Incorporation, State or Country Code DE    
Entity Tax Identification Number 46-4464131    
Entity Address, Address Line One 570 10th Street    
Entity Address, City or Town Oakland,    
Entity Address, State or Province CA    
Entity Address, Postal Zip Code 94607    
City Area Code (510)    
Local Phone Number 778-7787    
Title of 12(b) Security Common Stock, $0.01 par value    
Trading Symbol ELF    
Security Exchange Name NYSE    
Entity Well-known Seasoned Issuer Yes    
Entity Voluntary Filers No    
Entity Current Reporting Status Yes    
Entity Interactive Data Current Yes    
Entity Filer Category Large Accelerated Filer    
Entity Small Business false    
Entity Emerging Growth Company false    
ICFR Auditor Attestation Flag true    
Document Financial Statement Error Correction [Flag] false    
Entity Shell Company false    
Entity Public Float     $ 4.2
Entity Common Stock, Shares Outstanding   55,939,080  
Documents Incorporated by Reference
Portions of the registrant’s Definitive Proxy Statement relating to the registrant’s 2024 annual meeting of stockholders are incorporated by reference into Part III of this Annual Report on Form 10-K. Such Definitive Proxy Statement will be filed with the Securities and Exchange Commission within 120 days of the registrant's fiscal year ended March 31, 2024.
   
Amendment Flag false    
Document Fiscal Year Focus 2024    
Document Fiscal Period Focus FY    
Entity Central Index Key 0001600033    
v3.24.1.1.u2
Audit Information
12 Months Ended
Mar. 31, 2024
Audit Information [Abstract]  
Auditor Name Deloitte & Touche LLP
Auditor Location San Francisco, CA
Auditor Firm ID 34
v3.24.1.1.u2
Consolidated balance sheets - USD ($)
$ in Thousands
Mar. 31, 2024
Mar. 31, 2023
Current assets:    
Cash and cash equivalents $ 108,183 $ 120,778
Accounts receivable, net 123,797 67,928
Inventory, net 191,489 81,323
Prepaid expenses and other current assets 53,608 33,296
Total current assets 477,077 303,325
Property and equipment, net 13,974 7,874
Intangible assets, net 225,094 78,041
Goodwill 340,600 171,620
Other assets 72,502 34,741
Total assets 1,129,247 595,601
Current liabilities:    
Current portion of long-term debt and finance lease obligations 100,307 5,575
Accounts payable 81,075 31,427
Accrued expenses and other current liabilities 117,733 70,974
Total current liabilities 299,115 107,976
Long-term debt and finance lease obligations 161,819 60,881
Deferred tax liabilities 3,666 3,742
Long-term operating lease obligations 21,459 11,201
Other long-term liabilities 616 784
Total liabilities 486,675 184,584
Commitments and contingencies (Note 10)
Stockholders’ equity:    
Common stock, par value of $0.01 per share; 250,000,000 shares authorized as of March 31, 2024 and March 31, 2023; 55,583,660 and 53,770,482 shares issued and outstanding as of March 31, 2024 and March 31, 2023, respectively 555 535
Additional paid-in capital 936,403 832,481
Accumulated other comprehensive loss (50) 0
Accumulated deficit (294,336) (421,999)
Total stockholders’ equity 642,572 411,017
Total liabilities and stockholders’ equity $ 1,129,247 $ 595,601
v3.24.1.1.u2
Consolidated balance sheets (Parenthetical) - $ / shares
Mar. 31, 2024
Mar. 31, 2023
Statement of Financial Position [Abstract]    
Common stock, par value (in USD per share) $ 0.01 $ 0.01
Common stock, shares authorized (in shares) 250,000,000 250,000,000
Common stock, shares issued (in shares) 55,583,660 53,770,482
Common stock, shares outstanding (in shares) 55,583,660 53,770,482
v3.24.1.1.u2
Consolidated statements of operations - USD ($)
$ in Thousands
12 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Mar. 31, 2022
Income Statement [Abstract]      
Net sales $ 1,023,932 $ 578,844 $ 392,155
Cost of sales 299,836 188,448 140,423
Gross profit 724,096 390,396 251,732
Selling, general and administrative expenses 574,418 322,253 221,912
Restructuring expense 0 0 50
Operating income 149,678 68,143 29,770
Other income (expense), net 1,210 (1,875) (1,438)
Impairment of equity investment (2,875) 0 0
Interest expense, net (7,023) (2,018) (2,441)
Loss on extinguishment of debt 0 (176) (460)
Income before provision for income taxes 140,990 64,074 25,431
Income tax provision (13,327) (2,544) (3,661)
Net income $ 127,663 $ 61,530 $ 21,770
Net income per share:      
Basic (in USD per share) $ 2.33 $ 1.17 $ 0.43
Diluted (in USD per share) $ 2.21 $ 1.11 $ 0.41
Weighted average shares outstanding:      
Basic (in shares) 54,747,930 52,474,811 50,940,808
Diluted (in shares) 57,788,454 55,337,554 53,654,303
v3.24.1.1.u2
Consolidated statements of comprehensive income - USD ($)
$ in Thousands
12 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Mar. 31, 2022
Statement of Comprehensive Income [Abstract]      
Net income $ 127,663 $ 61,530 $ 21,770
Other comprehensive loss, net of tax      
Foreign currency translation adjustment (50) 0 0
Other comprehensive loss, net of tax (50) 0 0
Comprehensive income $ 127,613 $ 61,530 $ 21,770
v3.24.1.1.u2
Consolidated statements of stockholders' equity - USD ($)
$ in Thousands
Total
Common stock
Additional paid-in capital
Accumulated other comprehensive loss
Accumulated deficit
Beginning balance (in shares) at Mar. 31, 2021   50,400,510      
Beginning balance at Mar. 31, 2021 $ 269,646 $ 504 $ 774,441 $ 0 $ (505,299)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income 21,770       21,770
Stock based compensation 19,336   19,336    
Exercise of stock options and vesting of restricted stock (in shares)   1,123,797      
Exercise of stock options and vesting of restricted stock 1,677 $ 11 1,666    
Foreign currency translation adjustment 0        
Ending balance (in shares) at Mar. 31, 2022   51,524,307      
Ending balance at Mar. 31, 2022 312,429 $ 515 795,443 0 (483,529)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income 61,530       61,530
Stock based compensation 29,005   29,005    
Exercise of stock options and vesting of restricted stock (in shares)   2,047,270      
Exercise of stock options and vesting of restricted stock 8,053 $ 20 8,033    
Foreign currency translation adjustment $ 0        
Ending balance (in shares) at Mar. 31, 2023 53,770,482 53,571,577      
Ending balance at Mar. 31, 2023 $ 411,017 $ 535 832,481 0 (421,999)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income 127,663       127,663
Stock based compensation 40,609   40,609    
Exercise of stock options and vesting of restricted stock (in shares)   1,359,300      
Exercise of stock options and vesting of restricted stock 5,561 $ 14 5,547    
Issuance of common stock as consideration for Acquisition (in shares)   577,659      
Issuance of common stock as consideration for Acquisition 57,772 $ 6 57,766    
Foreign currency translation adjustment $ (50)     (50)  
Ending balance (in shares) at Mar. 31, 2024 55,583,660 55,508,536      
Ending balance at Mar. 31, 2024 $ 642,572 $ 555 $ 936,403 $ (50) $ (294,336)
v3.24.1.1.u2
Consolidated statements of cash flows - USD ($)
$ in Thousands
12 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Mar. 31, 2022
Cash flows from operating activities:      
Net income $ 127,663 $ 61,530 $ 21,770
Adjustments to reconcile net income to net cash provided by operating activities:      
Depreciation and amortization 35,913 22,164 27,083
Restructuring expense 0 0 50
Stock based compensation expense 40,625 29,117 19,646
Amortization of debt issuance costs and discount on debt 430 346 394
Deferred income taxes (3,276) (6,401) (3,701)
Impairment of equity investment 2,875 0 0
Acquisition-related seller expenses (10,549) 0 0
Loss on extinguishment of debt 0 176 460
Other, net 1,227 179 496
Changes in operating assets and liabilities:      
Accounts receivable (49,598) (22,432) (5,597)
Inventory (93,930) 3,174 (27,655)
Prepaid expenses and other assets (55,182) (24,553) (10,555)
Accounts payable and accrued expenses 81,215 42,995 1,498
Other liabilities (6,259) (4,412) (4,376)
Net cash provided by operating activities 71,154 101,883 19,513
Cash flows from investing activities:      
Acquisition, net of cash acquired (274,973) 0 0
Purchase of property and equipment (8,659) (1,723) (4,818)
Investment contributions (1,028) 0 0
Net cash used in investing activities (284,660) (1,723) (4,818)
Cash flows from financing activities:      
Proceeds from revolving line of credit 89,500 0 26,480
Repayment of revolving line of credit 0 0 (26,480)
Proceeds from long-term debt 115,000 0 25,581
Repayment of long-term debt (7,875) (30,000) (54,525)
Debt issuance costs paid (665) 0 (1,064)
Cash received from issuance of common stock 5,561 8,053 1,677
Other, net (576) (788) (779)
Net cash provided by (used in) financing activities 200,945 (22,735) (29,110)
Effect of exchange rate changes on cash and cash equivalents (34) 0 0
Net (decrease) increase in cash and cash equivalents (12,595) 77,425 (14,415)
Cash and cash equivalents - beginning of period 120,778 43,353 57,768
Cash and cash equivalents - end of period 108,183 120,778 43,353
Supplemental disclosure of cash flow information:      
Cash paid for interest 11,265 3,546 1,762
Cash paid for income taxes, net of refunds 12,396 13,369 7,573
Cash paid for interest on finance leases 6 32 63
Supplemental disclosure of noncash investing and financing activities:      
Issuance of common stock as consideration for acquisition 57,772 0 0
Property and equipment purchases included in accounts payable and accrued expenses $ 1,632 $ 335 $ 390
v3.24.1.1.u2
Nature of operations
12 Months Ended
Mar. 31, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Nature of operations Nature of operations
e.l.f. Beauty, Inc., a Delaware corporation (“e.l.f. Beauty” and together with its subsidiaries, the “Company”), is a multi-brand beauty company that offers inclusive, accessible, clean, vegan and cruelty free cosmetics and skin care products. The Company's mission is to make the best of beauty accessible to every eye, lip, face and skin concern.
e.l.f. Beauty believes its ability to deliver cruelty free, clean, vegan and premium-quality products at accessible prices with broad appeal differentiates it in the beauty industry. e.l.f. Beauty believes the combination of its value proposition, innovation engine, ability to attract and engage consumers, and its world-class team’s ability to execute with speed, has positioned the Company well to navigate the competitive beauty market.
The Company's family of brands includes e.l.f. Cosmetics, e.l.f. SKIN, Naturium, Well People and Keys Soulcare. The Company's brands are available online and across leading beauty, mass-market and specialty retailers. The Company has strong relationships with its retail customers such as Target, Walmart, Ulta Beauty and other leading retailers that have enabled the Company to expand distribution both domestically and internationally.
v3.24.1.1.u2
Summary of significant accounting policies
12 Months Ended
Mar. 31, 2024
Accounting Policies [Abstract]  
Summary of significant accounting policies Summary of significant accounting policies
Basis of presentation
The consolidated financial statements and related notes have been prepared in accordance with US generally accepted accounting principles (“US GAAP”) and all intercompany balances and transactions have been eliminated in consolidation.
Use of estimates
The preparation of financial statements in conformity with US GAAP requires management make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and reported amounts of revenues and expenses during the reporting period. Actual results could differ from these estimates.
Cash and cash equivalents
Cash and cash equivalents include all cash balances and highly liquid investments purchased with maturities of three months or less.
Accounts receivable
Trade receivables consist of uncollateralized, non-interest bearing customer obligations from transactions with the Company's customers, reduced by an allowance for doubtful accounts for estimated losses resulting from the inability of customers to make payments. The allowance is based on the evaluation and aging of past due balances, specific exposures, historical trends and economic conditions.
The Company maintains allowances for doubtful accounts for uncollectible accounts receivable. Management estimates anticipated losses from doubtful accounts based on days past due, collection history and the financial health of customers. The Company writes off accounts receivable against the allowance when a balance is determined to be uncollectible. Recoveries of receivables previously written off are recorded when received. The Company recorded an allowance for doubtful accounts of $1.2 million and $0.1 million as of March 31, 2024 and March 31, 2023, respectively. The Company recorded a reserve for sales adjustments of $38.7 million and $23.5 million as of March 31, 2024 and March 31, 2023, respectively, which is also presented as a reduction to accounts receivable. The Company grants credit terms in the normal course of business to its customers. Trade credit is extended based upon an evaluation of each customer’s ability to perform its payment obligations.
Concentrations of credit risk
Financial instruments, which potentially subject the Company to concentrations of credit risk, consist principally of cash and cash equivalents including money market funds. Although the Company deposits its cash with creditworthy financial institutions, its deposits, at times, may exceed federally insured limits. To date, the Company has not experienced any losses on its cash deposits. The Company performs credit evaluations of its customers and the risk with respect to trade receivables is further mitigated by the short duration of customer payment terms and the pedigree of the customer base.
During the fiscal years ended March 31, 2024, March 31, 2023 and March 31, 2022, the following customers individually accounted for greater than 10% of the Company’s net sales as disclosed below:
Fiscal year ended March 31,
202420232022
Target25 %25 %23 %
Walmart17 %20 %26 %
Ulta Beauty16 %15 %12 %
Customers that individually accounted for greater than 10% of the Company’s accounts receivable at the end of the periods as of March 31, 2024 and March 31, 2023, respectively, are as presented:
March 31, 2024March 31, 2023
Target28 %32 %
Walmart20 %26 %
Ulta Beauty12 %*
* Customer comprised less than 10% of accounts receivable at the end of the period indicated.
Inventory
Inventory, consisting principally of finished goods, is stated at the lower of cost and net realizable value. Cost is principally determined by the first-in, first-out method. The Company also records a reserve for excess and obsolete inventory, which represents the excess of the cost of the inventory over its estimated market value. This reserve is based upon an assessment of historical trends, current market conditions and forecasted product demand. The Company recorded an adjustment for excess and obsolete inventory, which is presented as a reduction to inventory of $10.6 million and $6.6 million as of March 31, 2024 and March 31, 2023, respectively.
Property and equipment and other assets
Property and equipment is stated at cost and is depreciated on a straight-line basis over the estimated useful lives of the assets. Leasehold improvements are amortized on a straight-line basis over the shorter of the lease term or the useful lives of the assets. Repairs and maintenance expenditures are expensed as incurred.
Useful lives by major asset class are as follows:
 Estimated useful lives
Machinery, equipment and software
2 - 5 years
Leasehold improvements
up to 5 years
Furniture and fixtures
3 - 5 years
Store fixtures
1 - 3 years
As of March 31, 2024 and March 31, 2023, included in other assets are retail product displays, net, of $41.1 million and $15.7 million, respectively, that are generally amortized over a period of three years. Amortization expense for retail product
displays was $11.4 million, $5.2 million and $5.9 million for the fiscal years ended March 31, 2024, March 31, 2023 and March 31, 2022, respectively.
The Company evaluates events and changes in circumstances that could indicate carrying amounts of long-lived assets, including property and equipment, may not be recoverable. When such events or changes in circumstances occur, the Company assesses the recoverability of long-lived assets by determining whether or not the carrying value of such assets will be recovered through undiscounted future cash flows derived from their use and eventual disposition. For purposes of this assessment, long-lived assets are grouped with other assets and liabilities at the lowest level for which identifiable cash flows are largely independent of the cash flows of other assets and liabilities. The Company’s long-lived assets are grouped on an entity-wide basis. This is due, in part, to the integrated nature of the Company’s various distribution channels and the extent of shared costs across those channels. If the sum of the undiscounted future cash flows is less than the carrying amount of an asset, the Company records an impairment loss for the amount by which the carrying amount of the assets exceeds its fair value. There were no impairment charges recorded on long-lived assets during the fiscal years ended March 31, 2024, March 31, 2023 and March 31, 2022, respectively.
Goodwill and intangible assets
Goodwill represents the excess of the purchase price for an acquisition over the fair value of the net assets acquired. In addition, the Company has acquired finite-lived intangible assets and an indefinite-lived intangible asset.
Goodwill is not amortized but rather is reviewed annually for impairment, at the reporting unit level, or when there is evidence that events or changes in circumstances indicate that the Company’s carrying amount may not be recovered. When testing goodwill for impairment, the Company first performs an assessment of qualitative factors. If qualitative factors indicate that it is more likely than not that the fair value of the relevant reporting unit is less than its carrying amount, the Company tests goodwill for impairment at the reporting unit level using a two-step approach. In step one, the Company determines if the fair value of the reporting unit exceeds the unit’s carrying value. If step one indicates that the fair value of the reporting unit is less than its carrying value, the Company performs step two, determining the fair value of goodwill and, if the carrying value of goodwill exceeds its implied fair value, an impairment charge is recorded. The Company has identified a single reporting unit for purposes of impairment testing due, in part, to the integrated nature of the Company’s various distribution channels and the extent of shared costs across those channels.
Indefinite-lived intangible assets are not amortized but rather are tested for impairment annually and impairment is recognized if the carrying amount exceeds the fair value of the intangible asset. The Company evaluates its indefinite-lived intangible asset to determine whether current events and circumstances continue to support an indefinite useful life. Amortization of intangible assets with finite useful lives is computed on a straight-line basis over periods of 3 years to 15 years. The determination of the estimated period of benefit is dependent upon the use and underlying characteristics of the intangible asset. The Company evaluates the recoverability of its intangible assets subject to amortization when facts and circumstances indicate that the carrying value of the asset may not be recoverable. If the carrying value of an intangible asset is not recoverable, impairment loss is measured as the amount by which the carrying value exceeds its estimated fair value. There were no impairment charges recorded on goodwill or indefinite-lived intangible assets during the fiscal years ended March 31, 2024, March 31, 2023 or March 31, 2022.
Debt issuance costs
Debt issuance costs and lender fees were incurred for arranging the credit facilities from various financial institutions. For credit facilities consisting of both term and revolving debt, such costs are allocated to each sub-facility based upon the total borrowing capacity. For term debt, issuance costs are presented within the related long-term debt liability on the consolidated balance sheet and lender fees are presented as a direct deduction from the carrying amount. Both debt issuance costs and lender fees are amortized over the term of the related debt using the effective interest rate method. For revolving debt, issuance costs and lender fees are presented as a noncurrent asset and amortized over the term of the related debt on a straight-line basis.
Fair value of financial instruments
The carrying amounts of cash and cash equivalents, accounts receivable and accounts payable and accrued expenses approximate their fair values due to the short-term nature of these items. The carrying amounts of bank debt approximate their fair values as the stated interest rates approximate market rates currently available to the Company for loans with similar terms. See Note 8 Fair value of financial instruments to consolidated financial statements in Part IV, Item 15.“Exhibits, financial statement schedules.”
Segment reporting
Operating segments are components of an enterprise for which separate financial information is available that is evaluated by the chief operating decision maker in deciding how to allocate resources and in assessing performance. Utilizing these criteria, the Company manages its business on the basis of one operating segment and one reportable segment. It is impracticable for the Company to provide revenue by product line.
During the fiscal years ended March 31, 2024, March 31, 2023 and March 31, 2022, net sales in the United States and International were as follows (in thousands):
Fiscal year ended March 31,
202420232022
United States$868,076 $506,759 $347,484 
International155,856 72,085 44,671 
Total net sales$1,023,932 $578,844 $392,155 
As of March 31, 2024 and March 31, 2023, the Company had property and equipment in the United States and International as follows (in thousands):
March 31, 2024March 31, 2023
United States$10,936 $7,606 
International3,038 268 
Total property and equipment, net$13,974 $7,874 
Business combinations
The purchase price of a business acquisition is allocated to the assets acquired and liabilities assumed based upon their estimated fair values at the business combination date. The excess of purchase price over the fair value of assets acquired and liabilities assumed is recorded as goodwill. Determining fair value of identifiable assets, particularly intangibles, and liabilities acquired also requires the Company to make estimates, which are based on all available information and in some cases assumptions with respect to the timing and amount of future revenues and expenses associated with an asset. Unanticipated events or circumstances may occur that could affect the accuracy of the Company’s fair value estimates, and under different assumptions, the resulting valuations could be materially different.
Costs that are incurred to complete the business combination, such as legal and other professional fees, are not considered as a part of consideration transferred and are charged to selling, general and administrative expense as they are incurred.
Revenue recognition
Revenue is recognized when control of promised goods or services is transferred to a customer in an amount that reflects the consideration that the Company expects to receive in exchange for those goods or services.
For the Company’s retail customer transactions, a contract exists when a written purchase order is received. For the Company’s direct-to-consumer transactions, a contract exists when an order is placed online. Control transfers at the time of shipment or the time of delivery, depending upon the specific terms of the customer arrangement. Nearly all of the Company’s transactions with its customers and consumers include a single performance obligation delivered at a point in time.
The transaction price can include both fixed and variable consideration. In most cases, it is entirely comprised of variable consideration with the variability driven by expected sales discounts, markdown support and other incentives and allowances offered to customers. These incentives may be explicit or implied by the Company's historical business practices. Generally, these commitments represent cash consideration paid to a customer and do not constitute a promised good or service.
The amount of variable consideration is estimated at the time of sale based on either the expected amount or the most likely amount, depending on the nature of the variability. The Company regularly reviews and revises, when deemed necessary, its estimates of variable consideration, based on both customer-specific expectations as well as historical rates of realization. A provision for customer incentives and allowances is included on the consolidated balance sheet, net against accounts receivable.
Disaggregated revenue
The Company distributes product both through national and international retailers as well as direct-to-consumers through its e-commerce channels. The marketing and consumer engagement benefits that the direct channels provide are integral to the Company’s brand and product development strategy and drive sales across channels. As such, the Company views its two primary distribution channels as components of one integrated business, as opposed to discrete revenue streams.
The Company sells a variety of beauty products but does not consider them to be meaningfully different revenue streams given similarities in the nature of the products, the target consumer and the innovation and distribution processes. See Segment Reporting section above for the table providing disaggregated revenue from contracts with customers by geographical market, as the nature, amount, timing and uncertainty of revenue and cash flows can differ between domestic and international customers.
Contract assets and liabilities
The Company extends credit to its retail customers based upon an evaluation of their credit quality. The majority of retail customers obtain payment terms of approximately 30 days and a contract asset is recognized for the related accounts receivable. Additionally, shipping terms can vary, giving rise to contract liabilities for contracts where payment has been received in advance of delivery. The contract liability balance can vary significantly depending on the timing of when an order is placed and when shipment or delivery occurs.
As of March 31, 2024, other than accounts receivable, the Company had no material contract assets, contract liabilities or deferred contract costs recorded on its consolidated balance sheet.
Practical expedients
The Company elected to record revenue net of taxes collected from customers and exclude the amounts from the transaction price. The Company includes in revenue any taxes assessed on the Company's total gross receipts for which it has the primary responsibility to pay the tax.
The Company elected not to disclose revenues related to remaining performance obligations for partially completed or unfulfilled contracts that are expected to be fulfilled within one year as such amounts were insignificant.
A reconciliation of the beginning and ending amounts of the reserve for sales adjustments for the fiscal years ended March 31, 2024, March 31, 2023 and March 31, 2022 is as follows (in thousands):
Balance as of March 31, 2021$11,913 
Charges48,862 
Deductions(44,465)
Balance as of March 31, 202216,310 
Charges66,302 
Deductions(59,092)
Balance as of March 31, 202323,520 
Charges122,228 
Deductions(107,088)
Balance as of March 31, 2024$38,660 
In the fiscal years ended March 31, 2024, March 31, 2023 and March 31, 2022, the Company recorded $3.4 million, $1.6 million and $0.7 million, respectively, of reimbursed shipping expenses from customers within revenues. The shipping and handling costs associated with product distribution were $57.1 million, $36.9 million and $28.0 million, in the fiscal years ended March 31, 2024, March 31, 2023 and March 31, 2022, respectively, and are included in selling, general and administrative expenses in the consolidated statements of operations.
Income taxes
Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and operating loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. Valuation allowances are recorded to reduce deferred tax assets when it is more likely than not that a tax benefit will not be realized.
Future income tax benefits are recognized to the extent that realization of such benefits is more likely than not. The Company recognizes interest and penalties, if any, related to unrecognized tax benefits in its income tax provision.
Leases
The Company has entered into operating lease agreements for office space, warehouse and equipment and software. Lease assets and liabilities are recognized at the present value of the minimum rental payments (excluding executory costs) and expected payment under any residual value guarantee at the lease commencement date. The Company uses its incremental borrowing rate to determine the present value of lease payments.
Non-lease components primarily include payments for maintenance and utilities. The Company accounts for the non-lease components in a contract (e.g., common area maintenance) as part of the lease component by electing practical expedient for all leases of commercial office and warehouse space, as the non-lease components are not a significant portion of the total consideration in those agreements. The Company's lease terms include periods under options to extend or terminate the lease when it is reasonably certain that the Company will exercise that option.
Operating lease assets and liabilities are included on the Company's consolidated balance sheet. The current portion of the Company's operating lease liabilities is included in accrued expenses and other current liabilities and the long-term portion is included in long-term operating lease liabilities. Finance lease assets are included in other assets. Finance lease liabilities are included in long-term debt and finance lease obligations. Operating lease expense is recognized on a straight-line basis over the lease term.
Foreign currency
The functional currency of most of the Company’s foreign subsidiaries as of March 31, 2024 is the US dollar. During the current reporting period, the Company reassessed its functional currency and determined that the functional currency for one of its foreign subsidiaries changed from the US dollar to GBP. The change in functional currency is accounted for prospectively from October 1, 2023. Prior to the change, the functional currency of all of the Company’s foreign subsidiaries is the US dollar. Transactions denominated in currencies other than the functional currency are recorded at exchange rates in effect on the date of the transaction. At the end of each reporting period, monetary assets and liabilities are remeasured to the functional currency using exchange rates in effect at the balance sheet date. Non-monetary assets and liabilities are remeasured at historical exchange rates. Unrealized foreign exchange gains and losses due to re-measurement of monetary assets and liabilities denominated in non-functional currencies as well as transaction gains or losses that arise from exchange rate fluctuations on transactions denominated in a currency other than the functional currency are included in other income (expense), net in the consolidated statements of operations.
The financial statements of the non-US dollar functional currency subsidiary are translated into US dollars using period-end rates of exchange for assets and liabilities, historical rates of exchange for equity and average rates of exchange for revenue and expenses. Translation gains (losses) are recorded in accumulated other comprehensive income (loss) as a component of stockholders’ equity.
Stock based compensation
The Company has several stock award plans, which are described in detail in Note 13. The Company accounts for stock based compensation under ASC 718, “Compensation-Stock Compensation.” The Company recognizes expense over the requisite service period of the award, net of an estimate for the impact of award forfeitures.
Advertising costs
Advertising costs are expensed as incurred or distributed. Advertising costs are included in selling, general and administrative expenses in the accompanying consolidated statements of operations and amounted to approximately $209.2 million, $96.7 million and $41.0 million in the fiscal years ended March 31, 2024, March 31, 2023 and March 31, 2022, respectively.
Net income per share
Basic net income per share is computed using net income available to common stockholders divided by the weighted-average number of common shares outstanding during the period. Diluted net income per share reflects the dilutive effects of stock options and restricted stock outstanding during the period, to the extent such securities would not be anti-dilutive and is determined using the treasury stock method.
Recent accounting pronouncements
No new accounting pronouncements issued but not yet adopted are expected to have a material impact on the Company’s consolidated financial statements.
v3.24.1.1.u2
Investments
12 Months Ended
Mar. 31, 2024
Investments, All Other Investments [Abstract]  
Investments Investments
The Company has certain investments included in other assets on its consolidated balance sheets. The Company has elected the measurement alternative for equity investments that do not have readily determinable fair values. The Company recorded an impairment charge on one of its investments of $2.9 million as a separate line under other expense, net during the fiscal year ended March 31, 2024, as an identified event or change in circumstances resulted in an indicator of impairment. The Company did not record an impairment charge on its investment during the fiscal years ended March 31, 2023 and March 31, 2022, respectively, as any identified events or changes in circumstances did not result in an indicator of impairment during those periods. Further, there were no observable price changes in orderly transactions for the identical or a similar investment of the same issuer during the fiscal years ended March 31, 2024, March 31, 2023 and March 31, 2022, respectively.
v3.24.1.1.u2
Acquisition
12 Months Ended
Mar. 31, 2024
Business Combination and Asset Acquisition [Abstract]  
Acquisition Acquisition
On October 4, 2023, the Company, through its wholly owned subsidiary, e.l.f. Cosmetics, Inc., completed its acquisition of Naturium LLC (“Naturium”) (including the indirect acquisition of equity interests in Naturium through the purchase of TCB-N Prelude Blocker Corp., a holding company) (the “Acquisition”), which furthered the Company’s mission to make the best of beauty accessible to every eye, lip, face and skin concern. Naturium is a skin care company that provides clinically effective products at an affordable price. The Company directly and indirectly acquired all rights, title and interest in and to the outstanding equity securities of Naturium for a purchase price of $333.0 million in a combination of cash and Company stock.
The following table summarizes the fair market value of the consideration transferred and how the Company calculates the goodwill resulting from the acquisition (in thousands):
Cash consideration$275,266 
Equity consideration (common stock issued)(1)
57,772 
Total consideration transferred333,038 
Less: Net assets acquired
Net assets acquired, excluding liability assumed for acquisition-related seller expenses$174,608 
Liability assumed for acquisition-related seller expenses(2)
(10,549)
Net assets acquired(164,059)
Goodwill$168,979 
(1) The fair market value of the $57.8 million common stock issued (equivalent to 577,659 shares of common stock) was determined on the basis of the opening market price of the Company’s stock of $100.01 per share on the acquisition date.
(2) In connection with the Acquisition, the Company paid Naturium’s acquisition-related expenses of $10.5 million recognized as an assumed liability at the acquisition date.
The Company incurred and expensed acquisition transaction costs of $3.4 million during the fiscal year ended March 31, 2024, which are included as a component of selling, general and administrative expenses in the consolidated statements of operations.
The Acquisition has been accounted for as a business combination under the acquisition method and, accordingly, the total purchase price is allocated to the tangible and intangible assets acquired and the liabilities assumed based on their respective fair values on the acquisition date. The purchase price allocation, deferred tax calculations and residual goodwill are preliminary and pending finalization. Naturium’s results of operations have been included in the Company's consolidated financial statements from the date of acquisition.
The following table presents the preliminary purchase price allocation recorded in the Company's condensed consolidated balance sheet on the acquisition date (in thousands):
Cash$293 
Accounts receivable7,388 
Inventory16,236 
Prepaid expenses and other current assets1,899 
Property and equipment— 
Goodwill(1)
168,979 
Intangible assets 162,100 
Total assets acquired356,895 
Accounts payable(15,897)
Accrued expenses and other current liabilities(6,025)
Net deferred tax liability(1,935)
Total liabilities assumed(23,857)
Total purchase price$333,038 
(1) The goodwill represents the excess value over both tangible and intangible assets acquired and liabilities assumed. The goodwill recognized in this transaction is primarily attributable to the Company’s expectation that Naturium can continue to expand distribution and deliver new skin care products. A substantial amount of the goodwill is expected to be deductible for tax purposes.
The Company made certain measurement period adjustments in the fourth quarter of fiscal 2024 resulting in an increase to goodwill of $0.4 million. None of the adjustments were individually material. There was no income statement impact on comparable prior periods presented as a result of these adjustments.
Intangible assets
The estimated fair values (all considered level 3 measurements) of the identifiable intangible assets acquired, their estimated useful lives and fair value methodology are as follows:
Fair ValueEstimated Useful Life
(in thousands)(in years)Fair Value Methodology
Customer relationships – retailers$20,000 10Excess earnings method
Customer relationships – e-commerce17,600 3Excess earnings method and with and without method
Trademarks124,500 15Relief from Royalty method
Total identified intangible assets$162,100 
Certain financial information (unaudited)
The amounts of Naturium’s net sales included in the Company's condensed consolidated financial statements from the date of acquisition and the net sales of the combined companies on an unaudited pro forma basis, had the acquisition date been April 1, 2022, are as follows (in thousands):
 Amount
Actual Naturium net sales from October 4, 2023 to March 31, 2024$53,421 
Supplemental pro forma combined net sales for the fiscal year ended March 31, 2024
1,065,726 
Supplemental pro forma combined net sales for the fiscal year ended March 31, 2023
628,751 
The unaudited pro forma financial information shown in the table above are presented for informational purposes only and are not indicative of the results of operations that would have been achieved if the acquisition had taken place at April 1, 2022 (the beginning of the comparable prior annual reporting period).
The pro forma earnings of the combined companies are not presented as the effects of the Acquisition in earnings are not material in relation to the overall consolidated financial statements.
v3.24.1.1.u2
Goodwill and other intangible assets
12 Months Ended
Mar. 31, 2024
Goodwill and Intangible Assets Disclosure [Abstract]  
Goodwill and other intangible assets Goodwill and other intangible assets
Information regarding the Company’s goodwill and intangible assets as of March 31, 2024 is as follows (in thousands):
 Estimated useful lifeGross carrying amountAccumulated amortizationNet carrying amount
Customer relationships – retailers10 years$97,600 $(73,393)$24,207 
Customer relationships – e-commerce3 years21,540 (6,874)14,666 
Trademarks
10 to 15 years
128,000 (5,579)122,421 
Total finite-lived intangibles247,140 (85,846)161,294 
TrademarksIndefinite63,800 — 63,800 
Goodwill340,600 — 340,600 
Total goodwill and other intangibles$651,540 $(85,846)$565,694 
Information regarding the Company’s goodwill and intangible assets as of March 31, 2023 is as follows (in thousands):
 Estimated useful lifeGross carrying amountAccumulated amortizationNet carrying amount
Customer relationships – retailers10 years$77,600 $(65,780)$11,820 
Customer relationships – e-commerce3 years3,940 (3,940)— 
Trademarks10 years3,500 (1,079)2,421 
Total finite-lived intangibles 85,040 (70,799)14,241 
TrademarksIndefinite63,800 — 63,800 
Goodwill 171,620 — 171,620 
Total goodwill and other intangibles $320,460 $(70,799)$249,661 
The Company has not recognized any impairment charges on its goodwill or intangible assets. Amortization expense on finite-lived intangible assets was $15.0 million for the fiscal year ended March 31, 2024, and $8.1 million for each of the fiscal years ended March 31, 2023 and March 31, 2022.
The estimated future amortization expense related to the finite-lived intangible assets, assuming no impairment as of March 31, 2024, is as follows (in thousands):
Year ending March 31,
2025$17,397 
202617,397 
202714,463 
202811,530 
202911,530 
Thereafter88,977 
Total$161,294 
v3.24.1.1.u2
Property and equipment
12 Months Ended
Mar. 31, 2024
Property, Plant and Equipment [Abstract]  
Property and equipment Property and equipment
Property and equipment as of March 31, 2024 and March 31, 2023 consists of the following (in thousands):
 March 31, 2024March 31, 2023
Machinery, equipment and software$20,222 $15,148 
Leasehold improvements6,982 4,677 
Furniture and fixtures1,542 1,263 
Store fixtures10,157 10,782 
Property and equipment, gross38,903 31,870 
Less: Accumulated depreciation and amortization(24,929)(23,996)
Property and equipment, net$13,974 $7,874 
Depreciation and amortization expense on property and equipment was $3.5 million, $4.3 million and $7.9 million during the fiscal years ended March 31, 2024, March 31, 2023 and March 31, 2022, respectively.
v3.24.1.1.u2
Accrued expenses and other current liabilities
12 Months Ended
Mar. 31, 2024
Payables and Accruals [Abstract]  
Accrued expenses and other current liabilities Accrued expenses and other current liabilities
Accrued expenses and other current liabilities as of March 31, 2024 and March 31, 2023 consists of the following (in thousands):
 March 31, 2024March 31, 2023
Accrued expenses$37,782 $22,726 
Accrued inventory16,478 1,330 
Accrued marketing29,282 23,761 
Current portion of operating lease liabilities7,016 4,510 
Accrued compensation17,423 13,098 
Taxes payable5,814 2,851 
Other current liabilities3,938 2,698 
Accrued expenses and other current liabilities$117,733 $70,974 
v3.24.1.1.u2
Fair value of financial instruments
12 Months Ended
Mar. 31, 2024
Fair Value Disclosures [Abstract]  
Fair value of financial instruments Fair value of financial instruments
The fair value of financial instruments are categorized based upon the level of judgment associated with the inputs used to measure their fair values. Fair value is measured using inputs from the three levels of the fair value hierarchy, which are described as follows:
Level 1—Quoted prices in active markets for identical assets or liabilities
Level 2—Quoted prices for similar assets and liabilities in active markets or inputs that are observable
Level 3—Inputs that are unobservable (for example, cash flow modeling inputs based on management’s assumptions)
The assets’ or liabilities’ fair value measurement level within the fair value hierarchy is based on the lowest level of any input that is significant to the fair value measurement. The following table sets forth the fair value of the Company’s financial liabilities by level within the fair value hierarchy as of March 31, 2024 (in thousands):
  Fair value measurements using
 Fair valueLevel 1Level 2Level 3
Financial liabilities:    
Long-term debt, including current portion (1)
$262,932 $— $262,932 $— 
Total financial liabilities$262,932 $— $262,932 $— 
__________________________
(1) Of this amount, $100.3 million is classified as current. The gross carrying amounts of the Company’s bank debt, before reduction of the debt issuance costs, approximate their fair values as the stated rates approximate market rates for loans with
similar terms.
The following table sets forth the fair value of the Company’s financial liabilities by level within the fair value hierarchy as of March 31, 2023 (in thousands):
  Fair value measurements using
 Fair valueLevel 1Level 2Level 3
Financial liabilities:    
Long-term debt, including current portion (1)
$66,883 $— $66,883 $— 
Total financial liabilities$66,883 $— $66,883 $— 
__________________________
(1) Of this amount, $5.6 million is classified as current. The gross carrying amounts of the Company’s bank debt, before reduction of the debt issuance costs, approximate their fair values as the stated rates approximate market rates for loans with similar terms.
The Company did not transfer any assets measured at fair value on a recurring basis to or from Level 1 or Level 2 for any of the periods presented.
v3.24.1.1.u2
Debt
12 Months Ended
Mar. 31, 2024
Debt Disclosure [Abstract]  
Debt Debt
The Company’s outstanding debt as of March 31, 2024 and March 31, 2023 consists of the following (in thousands):
 March 31, 2024March 31, 2023
Debt: 
Revolving line of credit(1)
$89,500 $— 
Term loan(1)
$173,375 $66,250 
Finance lease obligations57 633 
Total debt262,932 66,883 
Less: debt issuance costs(806)(427)
Total debt, net of issuance costs262,126 66,456 
Less: current portion(100,307)(5,575)
Long-term portion of debt$161,819 $60,881 
(1) See further discussion below. As of March 31, 2024, the Company was in compliance with all applicable financial covenants under the Amended Credit Agreement.
Amended Credit Agreement
On April 30, 2021, the Company amended and restated its prior credit agreement (as further amended, supplemented or modified from time to time, the “Amended Credit Agreement”) and refinanced all loans under the prior credit agreement. The Amended Credit Agreement has a five year term and consists of (i) a $100 million revolving credit facility (the “Amended Revolving Credit Facility”) and (ii) a $100 million term loan facility (the “Amended Term Loan Facility”).
All amounts under the Amended Revolving Credit Facility are available for draw until the maturity date on April 30, 2026. The Amended Revolving Credit Facility is collateralized by substantially all of the Company’s assets and requires payment of an unused fee ranging from 0.10% to 0.30% (based on the Company’s consolidated total net leverage ratio (as defined in the Amended Credit Agreement)) times the average daily amount of unutilized commitments under the Amended Revolving Credit Facility. The Amended Revolving Credit Facility also provides for sub-facilities in the form of a $7 million letter of credit and a $5 million swing line loan; however, all amounts drawn under the Amended Revolving Credit Facility cannot exceed $100 million. The unused balance of the Amended Revolving Credit Facility as of March 31, 2024 was $10.5 million.
Prior to the Second Amendment (as defined below), both the Amended Revolving Credit Facility and the Amended Term Loan Facility bore interest, at the borrowers’ option, at either (i) a rate per annum equal to an adjusted LIBOR rate determined by reference to the cost of funds for the United States US dollar deposits for the applicable interest period (subject to a minimum floor of 0%) plus an applicable margin ranging from 1.25% to 2.125% based on our consolidated total net leverage ratio (the “Applicable Margin”) or (ii) a floating base rate plus an applicable margin ranging from 0.25% to 1.125% based on our consolidated total net leverage ratio. On March 29, 2023, the Company amended the Amended Credit Agreement to transition the benchmark from LIBOR to an adjusted Secured Overnight Financing Rate (“SOFR”) (which is equal to the applicable SOFR plus 0.10%) (such transaction, the “First Amendment”). In connection with the First Amendment, all outstanding LIBOR loans were converted to SOFR loans. The annual interest rate for SOFR borrowings will be equal to term SOFR, subject to a floor of 0%, plus a margin ranging from 1.25% to 2.125%.
The interest rate as of March 31, 2024 for the Amended Revolving Credit Facility and the Amended Term Loan Facility was approximately 6.7%.
In accordance with ASC 470, Debt, the amendment to the Company’s prior credit agreement was accounted for as both a debt modification and partial debt extinguishment, which resulted in the recognition of a loss on extinguishment of debt of $0.5 million for the fiscal year ended March 31, 2022. The Company incurred and capitalized $1.1 million of new debt issuance costs related to the amendment.
In the fiscal year ended March 31, 2023, the Company recognized a loss on extinguishment of debt of approximately $0.2 million, primarily related to the partial prepayment of term loan borrowings in the amount of $25.0 million.
Second Amended Credit Agreement
On August 28, 2023, the Company entered into the Second Amendment to the Amended and Restated Credit Agreement (the “Second Amendment”). Pursuant to the Second Amendment, the Company may borrow incremental term loans in a principal amount equal to $115.0 million under the Amended Credit Agreement (the “Incremental Term Loan”). The Incremental Term Loan will bear interest at a rate per annum equal to, at the Company’s election, adjusted term SOFR or an alternate base rate as set forth in the Second Amendment, plus an interest rate margin, to be based on consolidated total net leverage ratio levels, ranging from, (i) in the case of SOFR loans, 1.50% to 2.375%; provided that if SOFR is less than 0.00%, such rate shall be deemed to be 0.00%, and (ii) in the case of alternate base rate loans, 0.50% to 1.375%; provided that if the alternate base rate is less than 1.00%, such rate shall be deemed to be 1.00%. The Incremental Term Loan amortizes at 5.00% per annum payable in equal quarterly installments of 1.25% per annum, commencing with the fiscal quarter ended on December 31, 2023. The Company used the Incremental Term Loan together with cash from its balance sheet and additional borrowings under its Amended Revolving Credit Facility to consummate the Acquisition (as defined in Note 4 hereto) and to pay related fees and expenses in connection with the Acquisition and Second Amendment.
The interest rate as of March 31, 2024 for the Incremental Term Loan was approximately 6.9%.
The Amended Credit Agreement contains a number of covenants that, among other things and subject to certain exceptions, restrict the Company’s ability to pay dividends and distributions or repurchase capital stock, incur additional indebtedness, create liens on assets, engage in mergers or consolidations and sell or otherwise dispose of assets. The Amended Credit Agreement also includes reporting, financial and maintenance covenants that require the Company to, among other things, comply with certain consolidated total net leverage ratios and consolidated fixed charge coverage ratios.
Aggregate future minimum principal payments are as follows (in thousands):
Year ending March 31, Term Loan
2025$100,250 
202610,750 
2027151,875 
Total$262,875 
Interest expense, net  
The components of interest expense, net are as follows (in thousands):
Fiscal year ended March 31,
 202420232022
Interest on term loan debt$8,294 $3,450 $1,708 
Amortization of debt issuance costs430 346 331 
Interest on revolving line of credit3,106 163 342 
Interest on finance leases10 31 63 
Interest income(4,817)(1,972)(3)
Interest expense, net$7,023 $2,018 $2,441 
v3.24.1.1.u2
Commitments and contingencies
12 Months Ended
Mar. 31, 2024
Commitments and Contingencies Disclosure [Abstract]  
Commitments and contingencies Commitments and contingencies
Legal Contingencies
From time to time, the Company is involved in legal proceedings, claims, and litigation arising in the ordinary course of business. The Company is not currently a party to any matters that management expects will have a material adverse effect on the Company’s consolidated financial position, results of operations or cash flows.
v3.24.1.1.u2
Income taxes
12 Months Ended
Mar. 31, 2024
Income Tax Disclosure [Abstract]  
Income taxes Income taxes
The components of income (loss) before the provision for income taxes are as follows (in thousands):
Fiscal year ended March 31,
 202420232022
Domestic$142,507 $64,850 $26,286 
Foreign(1,517)(776)(855)
Total$140,990 $64,074 $25,431 
The components of the benefit (provision) for income taxes are as follows (in thousands):
Fiscal year ended March 31,
 202420232022
Current:  
US federal$(12,505)$(7,065)$(5,637)
State(4,078)(1,854)(1,715)
Foreign(20)(26)(10)
Total current(16,603)(8,945)(7,362)
Deferred: 
US federal2,130 5,035 3,146 
State746 816 738 
Foreign400 550 (183)
Total deferred3,276 6,401 3,701 
Total (provision) benefit for income taxes$(13,327)$(2,544)$(3,661)
The following table presents a reconciliation of the federal statutory rate to the Company’s effective tax rate:
Fiscal year ended March 31,
202420232022
Federal statutory rate21.0 %21.0 %21.0 %
State tax, net of federal benefit1.8 %1.0 %2.6 %
State tax deferred rate change, net of federal benefit— %— %(0.1)%
Nondeductible business expenses0.4 %0.6 %0.4 %
Nondeductible employee compensation4.3 %2.5 %1.1 %
Provision-to-return adjustment(0.2)%(0.1)%(0.3)%
Uncertain tax positions— %— %0.1 %
Stock based compensation(18.4)%(20.3)%(12.0)%
Change in valuation allowance0.4 %(0.6)%1.5 %
Others0.2 %(0.1)%0.1 %
Effective tax rate9.5 %4.0 %14.4 %
The components of net deferred taxes arising from temporary differences are as follows (in thousands):
March 31, 2024March 31, 2023
Deferred tax assets:  
Compensation$222 $354 
Inventory and receivables13,465 9,976 
Accrued expenses3,782 2,734 
Stock compensation7,349 8,247 
Net operating losses1,188 571 
Right of use liability5,026 3,782 
Capitalized research and development2,051 858 
Other1,792 774 
Gross deferred tax assets34,875 27,296 
Valuation allowance(744)— 
Net deferred tax assets34,131 27,296 
Deferred tax liabilities:
Goodwill3,546 5,180 
Fixed assets and internally developed software5,746 2,451 
Intangible assets21,326 19,107 
Right of use asset4,801 3,359 
Other557 378 
Deferred tax liabilities35,976 30,475 
Net deferred tax liabilities$1,845 $3,179 
The deferred tax assets and liabilities are reported in the accompanying balance sheets as follows (in thousands):
March 31, 2024March 31, 2023
Deferred tax assets$1,821 $563 
Deferred tax liabilities3,666 3,742 
Net deferred tax liabilities$1,845 $3,179 
The valuation allowance was $0.7 million and zero as of March 31, 2024 and March 31, 2023, respectively, primarily relating to an investment impairment for which we do not believe a tax benefit is more likely than not to be realized.
As of March 31, 2024, the Company had gross federal, state and foreign net operating loss carryforwards of zero, $0.9 million and $4.6 million, respectively. The state net operating loss carryforwards can either be carried forward 20 years or indefinitely. The state net operating loss carryforwards will begin to expire in 2038. The foreign net operating loss carryforwards can either be carried forward 5 years or indefinitely and will begin to expire in 2027.
A reconciliation of the beginning and ending amount of unrecognized tax benefits is as follows (in thousands):
Fiscal year ended March 31,
 202420232022
Balance at beginning of year$442 $466 $458 
Increases for prior year tax positions— — — 
Increases for current year tax positions108 92 75 
Decreases for prior year tax positions(19)(10)(6)
Decreases due to settlements— — (61)
Decreases due to statutes lapsing(98)(106)— 
Balance at end of year$433 $442 $466 
If all of the Company’s unrecognized tax benefits as of March 31, 2024, March 31, 2023 and March 31, 2022 were recognized, $0.4 million, $0.4 million and $0.5 million, respectively, of unrecognized tax benefits, would impact the effective tax rate. The Company believes it is reasonably possible that $40 thousand of unrecognized tax benefits may reverse in the next twelve months.
The Company recognizes interest and penalties accrued related to unrecognized tax benefits in the provision for income taxes. The Company's liability for unrecognized tax benefits is recorded within other long-term liabilities on the consolidated balance sheet. The Company had $0.2 million and $0.2 million of accrued gross interest and penalties as of March 31, 2024 and March 31, 2023, respectively. The Company recognized net interest and penalties (benefit)/expense of $(21) thousand, $34 thousand and $27 thousand for the fiscal years ended March 31, 2024, March 31, 2023 and March 31, 2022, respectively.
The Company files income tax returns in the US federal jurisdiction and various state and foreign jurisdictions. As of March 31, 2024, with few exceptions, the Company or its subsidiaries are no longer subject to examination prior to tax fiscal year ended March 31, 2020.
The Organization for Economic Co-operation and Development has a framework to implement a global minimum corporate tax of 15% for companies with global revenues and profits above certain thresholds (referred to as "Pillar 2"), with certain aspects of Pillar 2 effective January 1, 2024 and other aspects effective January 1, 2025. While it is uncertain whether the U.S. will enact legislation to adopt Pillar 2, certain countries in which the Company operates have adopted the legislation, and other countries are in the process of introducing legislation to implement Pillar 2. The Company is continuing to evaluate and monitor but does not expect for Pillar 2 to have a material impact on the effective tax rate or the consolidated financial statements.
v3.24.1.1.u2
Preferred stock
12 Months Ended
Mar. 31, 2024
Equity [Abstract]  
Preferred stock Preferred stock
The Company has authorized 30,000,000 shares of preferred stock for issuance with a par value of $0.01 per share. There were no shares of preferred stock outstanding as of March 31, 2024 or March 31, 2023.
v3.24.1.1.u2
Stock based compensation
12 Months Ended
Mar. 31, 2024
Share-Based Payment Arrangement [Abstract]  
Stock based compensation Stock based compensation
Stock plans
The Company grants stock based awards under its 2016 Equity Incentive Award Plan (as amended) (the “2016 Plan”), which replaced its 2014 Equity Incentive Plan (the “2014 Plan”) and became effective immediately prior to the effectiveness of the Company’s registration statement on Form S-1 in September 2016. No grants have been made under the 2014 Plan since the Company’s initial public offering and no further awards will be granted thereunder. Any awards outstanding under the 2014 Plan that are forfeited or lapse unexercised will be added to the shares reserved and available for grant under the 2016 Plan. The 2016 Plan permits the grant of incentive stock options, non-statutory stock options, restricted stock and other stock- or cash-based awards to employees, officers, directors, advisors and consultants. The 2016 Plan allows for option grants of the Company’s common stock based on service, performance and market conditions.
During the fiscal year ended March 31, 2024, no stock options were issued. As of March 31, 2024, a total of 17,697,556 shares have been authorized for issuance under the 2016 Plan, and 8,618,008 remain available for grant. As of March 31, 2024, there were 64,525 options and awards outstanding under the 2014 Plan that, if forfeited, would increase the number of shares authorized for grant under the 2016 Plan.
Service-based vesting stock options
The following table summarizes the activity for options that vest solely based upon the satisfaction of a service condition as follows:
 Options
outstanding
Weighted-average exercise priceWeighted-average remaining
contractual life
(in years)
Aggregate intrinsic
values
(in thousands) (1)
Balance as of March 31, 20211,640,981 14.86 
Exercised(93,282)11.19   
Canceled or forfeited(4,200)26.63   
Balance as of March 31, 20221,543,499 15.05 5.1$16,686 
Exercised(519,009)12.82 
Balance as of March 31, 20231,024,490 $16.17 4.1$67,796 
Exercised(347,590)14.47 
Canceled or forfeited(2,900)26.84 
Balance as of March 31, 2024674,000 $17.01 3.3$120,660 
Exercisable, March 31, 2024650,000 $17.07 3.2$116,326 
(1) The aggregate intrinsic value is calculated as the difference between the exercise price of the underlying awards and the Company's closing stock price of $196.03, as reported on the New York Stock Exchange on March 28, 2024.
Additional information relating to service-based options is as follows (in thousands):
Fiscal year ended March 31,
 202420232022
Stock based compensation expense$147 $344 $924 
Intrinsic value of options exercised 45,542 18,015 1,695 
As of March 31, 2024, there was $0.1 million of total unrecognized compensation cost related to service-based stock options, which is expected to be recognized over the remaining weighted-average vesting period of 1.5 years.
No service-based stock options were granted during the fiscal years ended March 31, 2024, March 31, 2023 and March 31, 2022.
The determination of the fair value of stock options on the date of grant using a Black-Scholes option-pricing model is affected by the fair value of the underlying common stock, as well as assumptions regarding a number of variables that are complex, subjective and generally require significant judgment. The assumptions used in the Black-Scholes option-pricing model to calculate the fair value of stock options were:
Fair value of common stock
The fair value of shares of common stock underlying stock options is based on the closing stock price as quoted on the New York Stock Exchange on the date of grant.
Expected term
The expected term of the options represents the period of time that the options are expected to be outstanding. Options granted have a maximum contractual life of 10 years. Prior to the Company’s initial public offering of its common stock in September 2016, the Company estimated the expected term of the option based on the estimated timing of potential liquidity events. For grants upon or after the initial public offering, the Company estimated the expected term based upon the simplified method described in Staff Accounting Bulletin No. 107, as the Company did not have sufficient historical exercise data to provide a reasonable basis upon which to estimate expected term due to the limited period of time its equity shares had been publicly traded.
Expected volatility
As the Company did not have sufficient trading history for its common stock, the expected stock price volatility for the common stock was estimated by taking the average historic price volatility for industry peers based on daily price observations over a period equivalent to the expected term of the stock option grants. Industry peers consist of several public companies within the same industry, which are of similar size, complexity and stage of development. The Company intends to continue to consistently apply this process using the same or similar public companies until a sufficient amount of historical information regarding the volatility of its own share price becomes available, or unless circumstances change such that the identified companies are no longer similar to the Company, in which case, more suitable companies whose share prices are publicly available would be used in the calculation.
Risk-free interest rate
The risk-free interest rate was based on the US Treasury rate, with maturities similar to the expected term of the options.
Expected dividend yield
The Company does not anticipate paying any dividends in the foreseeable future. As such, the Company uses an expected dividend yield of zero.
Performance-based and market-based vesting stock options
The following table summarizes the activity for options that vest based upon the satisfaction of performance or market conditions as follows:
Options
outstanding
Weighted-average exercise price Weighted-average remaining
contractual life
(in years)
Aggregate intrinsic
values
(in thousands) (1)
Balance as of March 31, 20211,108,592 8.72 
Exercised(104,265)2.24 
Balance as of March 31, 20221,004,327 9.40 3.0$16,809 
Exercised(460,787)2.73 
Canceled or forfeited(25,800)26.84 
Balance as of March 31, 2023517,740 14.46 2.4$35,151 
Exercised(256,440)1.84   
Balance as of March 31, 2024261,300 26.84 2.9$44,209 
Exercisable, March 31, 2024261,300 26.84 2.9$44,209 
(1) The aggregate intrinsic value is calculated as the difference between the exercise price of the underlying awards and the Company's closing stock price of $196.03, as reported on the New York Stock Exchange on March 28, 2024.
As of March 31, 2024, there was no further unrecognized compensation cost related to performance-based and market-based vesting stock options.
Additional information relating to options that vest based upon the satisfaction of performance or market conditions is as follows (in thousands):
Fiscal year ended March 31,
202420232022
Intrinsic value of options exercised$27,718 $23,860 $2,921 
Restricted stock awards and restricted stock units
The following table summarizes the activities for restricted stock awards (“RSAs”) and restricted stock units (“RSUs”), including performance-based RSUs, as follows:
 Shares of restricted stock outstandingWeighted-average grant date fair value
Balance as of March 31, 20212,289,615 14.67 
Granted1,103,890 27.62 
Vested(926,250)14.50 
Canceled or forfeited(191,513)16.67 
Balance as of March 31, 20222,275,742 20.85 
Granted1,180,167 28.59 
Vested(1,066,516)18.88 
Canceled or forfeited(260,620)22.24 
Balance as of March 31, 20232,128,773 25.94 
Granted526,280 111.41 
Vested(649,592)24.57 
Canceled or forfeited(62,594)51.75 
Balance as of March 31, 20241,942,867 48.67 
The Company has historically granted both service based and performance-based RSUs to its executive officers. Service based RSUs vest over time based on continued employment of the participant. The performance-based RSUs vest based upon the achievement of certain performance goals and continued employment of the participant through the determination date of the achievement of the respective performance goals. Service based RSU awards are also granted annually to every Company employee, and vest over time based on continued employment of the participant.
As of March 31, 2024, there were 75,124 unvested shares subject to RSAs outstanding. Additional information relating to RSAs and RSUs (including performance-based RSUs), is as follows (in thousands):
Fiscal year ended March 31,
 202420232022
Stock based compensation expense:
Cost of sales$16 $112 $311 
Selling, general and administrative expense40,462 28,661 18,411 
Total$40,478 $28,773 $18,722 
Intrinsic value of restricted stock released$73,124 $47,713 $25,621 
As of March 31, 2024, there was $78.1 million of total unrecognized compensation cost related to unvested RSAs and RSUs (including performance-based RSUs), which is expected to be recognized over the remaining weighted-average vesting period of 1.7 years.
v3.24.1.1.u2
Repurchase of common stock
12 Months Ended
Mar. 31, 2024
Equity [Abstract]  
Repurchase of common stock Repurchase of common stock
On May 8, 2019, the Company announced that its board of directors authorized a share repurchase program to acquire up to $25.0 million of the Company’s common stock (the “Share Repurchase Program”). Purchases under the Share Repurchase Program may be made from time to time through a variety of methods, which may include open market purchases, privately negotiated transactions, block trades, accelerated share repurchase transactions, or by any combination of such methods. The timing and amount of any repurchases pursuant to the Share Repurchase Program will be determined based on market conditions, share price and other factors. The Share Repurchase Program does not have an expiration date, does not require the Company to repurchase any specific number of shares of its common stock, and may be modified, suspended or terminated at any time without notice. There is no guarantee that any additional shares will be purchased under the Share Repurchase Program and such shares are intended to be retired after purchase.
The covenants in the Amended Credit Agreement require the Company to be in compliance with certain leverage ratios to make repurchases under the Share Repurchase Program.
The Company did not repurchase any shares during the three and twelve months ended March 31, 2024. A total of $17.1 million remains available for purchase under the Share Repurchase Program as of March 31, 2024.
v3.24.1.1.u2
Employee benefit plan
12 Months Ended
Mar. 31, 2024
Retirement Benefits [Abstract]  
Employee benefit plan Employee benefit plan
The Company maintains a defined contribution 401(k) profit-sharing plan (the “401(k) Plan”) for eligible employees. Participants may make voluntary contributions up to the maximum amount allowable by law. The Company may make contributions to the 401(k) Plan on a discretionary basis which vest to the participants 100%. The Company made matching contributions of $0.7 million, $0.5 million and $0.4 million to the 401(k) Plan during the fiscal years ended March 31, 2024, March 31, 2023 and March 31, 2022, respectively.
v3.24.1.1.u2
Net income per share
12 Months Ended
Mar. 31, 2024
Earnings Per Share [Abstract]  
Net income per share Net income per share
The following is a reconciliation of the numerator and denominator in the basic and diluted net income per common share computations (in thousands, except share and per share data):
Fiscal year ended March 31,
 202420232022
Numerator:  
Net income$127,663 $61,530 $21,770 
Denominator:
Weighted average common shares outstanding — basic
54,747,930 52,474,811 50,940,808 
Dilutive common equivalent shares from equity awards3,040,524 2,862,743 2,713,495 
Weighted average common shares outstanding —diluted
57,788,454 55,337,554 53,654,303 
Net income per share:
Basic$2.33 $1.17 $0.43 
Diluted$2.21 $1.11 $0.41 
Weighted average anti-dilutive shares from outstanding equity awards excluded from diluted earnings per share
44,772 194,289 20,314 
v3.24.1.1.u2
Leases
12 Months Ended
Mar. 31, 2024
Leases [Abstract]  
Leases Leases
The Company leases warehouses, distribution centers, office space and equipment. The majority of the Company's leases include one or more options to renew, with renewal terms that can extend the lease term for up to five years. The exercise of lease renewal options is at the Company's sole discretion and such renewal options are included in the lease term if they are reasonably certain to be exercised. Certain leases also include options to purchase the leased asset. The Company's lease agreements do not contain any material residual value guarantees or material restrictive covenants. Most of the Company’s equipment leases are finance leases of assets used to operate its distribution center in Ontario, California.
Significant judgment is required to determine whether commercial contracts contain a lease for purposes of ASC 842. The Company uses its incremental borrowing rate to determine the present value of lease payments.
Supplemental balance sheet information related to leases as of March 31, 2024 and March 31, 2023 is as follows (in thousands):
 ClassificationMarch 31, 2024March 31, 2023
Assets
Operating lease assets Other assets$27,415 $14,071 
Finance lease assets (a)
Other assets— 245 
Total leased assets$27,415 $14,316 
Liabilities
Current
Operating Accrued expenses and other current liabilities$7,016 $4,510 
FinanceCurrent portion of long-term debt and finance lease obligations57 575 
Noncurrent
Operating Long-term operating lease obligations21,459 11,201 
FinanceLong-term debt and finance lease obligations— 58 
Total lease liabilities$28,532 $16,344 
___________________
(a) Finance leases are recorded net of accumulated amortization of $1.5 million and $3.4 million as of March 31, 2024 and March 31, 2023, respectively.
For the fiscal years ended March 31, 2024, March 31, 2023 and March 31, 2022, the components of operating and finance lease costs were as follows (in thousands):
Fiscal year ended March 31,
 Classification202420232022
Operating lease cost Selling, general and administrative (“SG&A”) expenses$7,341 $4,638 $4,686 
Finance lease cost
Amortization of leased assetsSG&A expenses210 420 436 
Interest on lease liabilitiesInterest expense, net10 31 63 
Total lease cost$7,561 $5,089 $5,185 
As of March 31, 2024, the aggregate future minimum lease payments under non-cancellable leases are as follows (in thousands):
Year ending March 31,Operating
leases
Finance
leases
Total
2025$8,332 $57 $8,389 
20268,898 — 8,898 
20275,537 — 5,537 
20282,419 — 2,419 
20291,956 — 1,956 
Thereafter5,417 — 5,417 
Total lease payments32,559 57 32,616 
Less: Interest4,084 — 4,084 
Present value of lease liabilities$28,475 $57 $28,532